- Home
- DDS vs BAX Comparison
DDS vs BAX Comparison
Compare DDS & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DDS | BAX |
|---|---|---|
| Founded | 1938 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.5B | 10.2B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | DDS | BAX |
|---|---|---|
| Price | $646.16 | $20.86 |
| Analyst Decision | Sell | Hold |
| Analyst Count | 3 | 10 |
| Target Price | ★ $511.33 | $25.00 |
| AVG Volume (30 Days) | 139.4K | ★ 8.8M |
| Earning Date | 02-24-2026 | 02-12-2026 |
| Dividend Yield | ★ 4.86% | 0.20% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 36.93 | N/A |
| Revenue | $6,625,563,000.00 | ★ $11,023,000,000.00 |
| Revenue This Year | $1.07 | $5.22 |
| Revenue Next Year | $0.57 | $1.98 |
| P/E Ratio | $17.37 | ★ N/A |
| Revenue Growth | N/A | ★ 3.90 |
| 52 Week Low | $282.24 | $17.40 |
| 52 Week High | $741.98 | $37.74 |
Technical Indicators
Market Signals| Indicator | DDS | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 52.52 | 62.14 |
| Support Level | $600.86 | $19.55 |
| Resistance Level | $627.26 | $20.19 |
| Average True Range (ATR) | 26.11 | 0.56 |
| MACD | -0.35 | 0.03 |
| Stochastic Oscillator | 59.30 | 82.68 |
Price Performance
Historical ComparisonAbout DDS Dillard's Inc.
Dillard's Inc is an American fashion apparel, cosmetics, and home furnishings retailer. Its stores offer a large variety of merchandise and feature products from both national and exclusive brand sources. The company also operates a general contracting construction company, CDI Contractors. CDI Contractors' business includes constructing and remodelling stores for Dillards. The merchandise selections include exclusive brand merchandise such as Antonio Melani, Gianni Bini, Daniel Cremieux, Roundtree & Yorke, and private-label merchandise, among others. The company operates in two business segments; Retail Operations and Construction. The Retail Operations segment generates maximum revenue for the company.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.